Clean, marine-sourced tripeptide collagen makes US debut

By Danielle Masterson

- Last updated on GMT

Dolcas MoriKol PR
Dolcas MoriKol PR

Related tags Collagen Collagen peptides Supplyside west Beauty from within

DolCas Biotech launches MoriKol, a highly bioavailable, low-dose, tripeptide collagen hydrolysate.

The clean, naturally derived, marine-based tripeptide collagen ingredient from kosher, warm-water fish will be showcased at Supplyside West in Las Vegas. The firm hails it as an alternative to bovine and porcine collagen. 

Dolcas is making this “beauty-from-within” ingredient available to US consumers at a low, clinically supported daily dose of just 1 g. It delivers a minimum of 15% of readily utilizable forms of peptides that are absorbed intact. MoriKol also promises the specific amino acid sequence essential to collagen’s structure, glycine-proline-hydroxyproline (GPH), and showing 3% GPH when tested. 

Shavon Jackson-Michel, ND, Director of Medical & Scientific Affairs at DolCas, says it’s a novel ingredient. “No US-marketed fish collagen has quantified collagen actives at this level of specificity. Many commercially available collagen hydrolysates available collagen hydrolysates require doses between 2.5-10g/day, but offer negligible quantities of bioavailable peptides. Bi- and tripeptides are the smallest absorbable units of collagen, and when provided in a finite amount, provide greater potential for restorative functions, including fibroblast recruitment to damaged areas and collagen formation from bioavailable building blocks.”

The flavorless and odorless product is also water- and temperature-stable for use in diverse applications. Unlike traditional collagen ingredients, MoriKol’s small, freely absorbable collagen peptides are of very low molecular weight (a 15% tripeptide standard), which allows for a low dose. MoriKol says their piscine-sourced collagen capsules are highly absorbable and bioactive. 

Jackson-Michel explains, “Collagen is the most abundant protein type in the human body. Supplemental collagen’s potential whole-body application, including “beauty from within,” joint health, sports performance, and cardiovascular and digestive system support is far-reaching.”

Related topics Manufacturers

Related event

View more

Charting the Path Ahead for CBD in Dietary Supplements

Webinar

The flood of CBD products onto the market despite the ingredient’s legal impediments has been unprecedented in the history of dietary supplements. The Hemp Farming Act, passed as part of the 2018 Farm Bill, removed the DEA hurdle for CBD (cannabidiol) from hemp. However, for FDA, the IND exclusion clause still prohibits the inclusion of CBD in dietary supplement, foods and beverages. This has not stemmed the tide of CBD product launches, whether those are dietary supplements, beverages, or food. Quality standards appear to be all over the place, as are the claims being made. While FDA has reined in some of the more egregious players, the Agency has remained largely passive. FDA is actively exploring potential pathways to permit certain cannabis-derived compounds in food or dietary supplements, but what are the key boxes that need to be ticked to move forward with CBD products that meet the quality standards required of mainstream products? What safety questions remain unanswered? Where do we stand on a potential NDI notification or GRAS no objection? What claims can be supported by the science? And what does the CBD space look like in five years? In this webinar, the NutraIngredients-USA editorial team has assembled an expert panel to tell you everything you need to know about CBD.

Related news

Follow us

Products

View more

Webinars